Page 15 - Olink Explore News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In a recent study posted to the bioRxiv*preprint server, researchers evaluated the serum proteomic signatures of long coronavirus disease (COVID) patients.

(2022-05-09 | NDAQ:OLK) University of Oxford adopts Olink technology to advance protein biomarker discovery and unravel mechanisms of disease

Brokerages expect Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) to post $20.14 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Olink Holding AB (publ)’s earnings. Olink Holding AB (publ) reported sales of $13.63 million in the same quarter last year, which would suggest a […]

Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Olink Holding AB provides a platform of products and services which are deployed across major biopharmaceutical companies and clinical and academic […]

Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) had its price objective dropped by The Goldman Sachs Group from $34.00 to $20.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective suggests a potential upside of 29.28% […]